NCI CCC® - UW Health

m e m b e r sthe proliferation and invasion ofmetastatic tumors.Caroline M. Alexander, PhDRichard A. Anderson, PhDEmery H. Bresnick, PhDRichard R. Burgess, PhDWade Bushman, MD, PhDPeggy J. Farnham, PhDFrances J. Fogerty, PhDAndreas Friedl, MDMichael K. Fritsch, MD, PhDDaniel S. Greenspan, PhDAnna Huttenlocher, MDPatricia J. Keely, PhDLaura L. Kiessling, PhDJames S. Malter, MDShigeki Miyamoto, PhDDeane F. Mosher, MDChristopher J. Murphy, DVM, PhDSean P. Palecek, PhDDonna M. Peters, PhDAlan C. Rapraeger, PhDJeffrey Ross, MDLinda A. Schuler, PhDLewis G. Sheffield, PhDNader Sheibani, PhDJohn P. Svaren, PhDDavid A. Wassarman, PhDJyoti J. Watters, PhDETIOLOGY &CHEMOPREVENTIONProgram Leader:Michael N. Gould, PhDThe mission of the Etiology &Chemoprevention Program is todetermine the causes of cancerand then translate this knowledgeto develop and evaluate drugs,vitamins, or other agents to try toreduce the risk of or delay thedevelopment of cancer.Nihal Amad, PhDElaine T. Alarid, PhDHoward H. Bailey, MDChristopher A. Bradfield, PhDGeorge T. Bryan, MD, PhDHerbert Chen, MDSteven S. Clark, PhDKelly H. Clifton, PhDDavid L. DeMets, PhDNorman R. Drinkwater, PhDCharles E. Elson, PhDWilliam E. Fahl, PhDRussell F. Jacoby, MDDavid F. Jarrard, MDColin R. Jefcoate, PhDCharles B. Kasper, PhDChristina M. Kendziorski, PhDPaul O. Larson, MDHasan Mukhtar, PhDR. Timothy Mulchay, PhDMichael A. Newton, PhDC. David Page, Jr., PhDMichael W. Pariza, PhDHenry C. Pitot, MD, PhDTomas A. Prolla, PhDLinda A. Schuler, PhDJude W. Shavlik, PhDLewis G. Sheffield, PhDJames A. Stewart, MDJames P. Thomas, MD, PhDAjit Kumar Verma, PhDRichard H. Weindruch, PhDGeorge Wilding, MDEXPERIMENTALTHERAPEUTICSProgram Leader:F. Michael Hoffmann, PhDThe specific aims of theExperimental Therapeutics Programare to identify novel mechanisms ofanticancer therapy and translatethem to clinical applications, toperform initial human clinical trials,and to move new therapies todisease specific settings.Nicholas L. Abbott, PhDDaniel M. Albert, MDMark R. Albertini, MDRobert Auerbach, PhDHoward H. Bailey, MDHirak S. Basu, PhDDavid J. Beebe, PhDPaul J. Bertics, PhDReginald C. Bruskewitz, MDRichard J. Chappell, PhDJames F. Cleary, MDHector F. DeLuca, PhDDavid L. DeMets, PhDAndreas Friedl, MDSamuel H. Gellman, PhDMichael N. Gould, PhDKrista K. Graven, MDKyle D. Holen, MDPaul R. Hutson, PharmDGuilherme L. Indig, PhDBrad S. Kahl, MDWeiyuan John Kao, PhDKyungMann Kim, PhDJill M. Kolesar, PharmDMichael R. Kosorok, PhDIlene D. Kurzman, EdDGlen S. Kwon, PhDGaret P. Lahvis, PhDFred T. Lee, Jr., MDRichard R. Love, MDGerard J.D. Marriott, PhDLaurence J. Marton, MDDouglas G. McNeel, MD, PhDShigeki Miyamoto, PhDSherry Morgan-Meadows, MDR. Timothy Mulcahy, PhDDaniel L. Mulkerin, MDTerry D. Oberley, MDRonald T. Raines, PhDH. Ian Robins, MD, PhDJoseph R. Robinson, PhDArnold E. Ruoho, PhDJoan H. Schiller, MDJulian C. Schink, MDBen Shen, PhDEric V. Shusta, PhDJames A. Stewart, MDSanthanam Swaminathan, PhDJames P. Thomas, MD, PhDJames A. Thomson, VMD, PhDJon S. Thorson, PhDRandal S. Tibbetts, PhDAnne M. Traynor, MDDavid M. Vail, DVMLynn Van Ummersen, MDJamey P. Weichert, PhDGeorge Wilding, MDWeixiong Zhong, MD, PhDMEMBERS continued on next pageAR 2002-03 • PAGE 15